ZA986089B - Novel IL-5 inhibiting 6-azauracil derivatives. - Google Patents

Novel IL-5 inhibiting 6-azauracil derivatives.

Info

Publication number
ZA986089B
ZA986089B ZA9806089A ZA986089A ZA986089B ZA 986089 B ZA986089 B ZA 986089B ZA 9806089 A ZA9806089 A ZA 9806089A ZA 986089 A ZA986089 A ZA 986089A ZA 986089 B ZA986089 B ZA 986089B
Authority
ZA
South Africa
Prior art keywords
inhibiting
novel
azauracil derivatives
azauracil
derivatives
Prior art date
Application number
ZA9806089A
Other languages
English (en)
Inventor
Jean Fernand Armand Lacrampe
Marc Gaston Venet
Eddy Jean Edgard Freyne
Gustaaf Maria Boeckx
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA986089B publication Critical patent/ZA986089B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA9806089A 1997-07-10 1998-07-09 Novel IL-5 inhibiting 6-azauracil derivatives. ZA986089B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97202118 1997-07-10

Publications (1)

Publication Number Publication Date
ZA986089B true ZA986089B (en) 2000-01-10

Family

ID=8228531

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9806089A ZA986089B (en) 1997-07-10 1998-07-09 Novel IL-5 inhibiting 6-azauracil derivatives.

Country Status (23)

Country Link
EP (1) EP1000040B1 (xx)
JP (1) JP2002511882A (xx)
KR (1) KR20010014049A (xx)
CN (1) CN1262679A (xx)
AR (1) AR013360A1 (xx)
AT (1) ATE364597T1 (xx)
AU (1) AU742145B2 (xx)
BR (1) BR9811678A (xx)
CA (1) CA2294145A1 (xx)
DE (1) DE69837922D1 (xx)
EE (1) EE200000016A (xx)
HR (1) HRP20000003A2 (xx)
HU (1) HUP0004687A3 (xx)
ID (1) ID24390A (xx)
IL (1) IL133916A0 (xx)
NO (1) NO20000063L (xx)
NZ (1) NZ502180A (xx)
PL (1) PL337947A1 (xx)
SK (1) SK183999A3 (xx)
TR (1) TR200000153T2 (xx)
TW (1) TW496865B (xx)
WO (1) WO1999002505A1 (xx)
ZA (1) ZA986089B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2338968C (en) * 1998-07-30 2010-04-27 Michael J. Coghlan Glucocorticoid-selective agents
EP0987265A1 (en) 1998-09-18 2000-03-22 Janssen Pharmaceutica N.V. Interleukin-5 inhibiting 6-azauracil derivatives
ID28880A (id) 1998-12-18 2001-07-12 Janssen Pharmaceutica Nv Obat-obat lunak penghambat il-5
CA2380759A1 (en) * 1999-08-06 2001-02-15 Janssen Pharmaceutica N.V. Interleukin-5 inhibiting 6-azauracil derivatives
AU2001270304A1 (en) 2000-07-07 2002-01-21 The Administrators Of The Tulane Educational Fund Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor
US7183276B2 (en) 2002-02-28 2007-02-27 Takeda Pharmaceutical Company Limited Azole compounds
WO2004071448A2 (en) * 2003-02-12 2004-08-26 Transtech Pharma Inc. Substituted azole derivatives as inhibitors of protein tyrosine phosphatases
GB0305575D0 (en) 2003-03-11 2003-04-16 Glaxo Group Ltd Novel compounds
AU2005247610A1 (en) * 2004-05-29 2005-12-08 7Tm Pharma A/S Substituted thiazoleacetic as crth2 ligands
DE102006049618A1 (de) * 2006-10-20 2008-05-08 Tschesche, Harald, Prof. Dr. Triazine und Ihre Verwendung als Metalloproteinase-Inhibitoren
CN101265238B (zh) * 2007-12-12 2010-06-16 重庆天极旅业有限公司 一种三嗪环衍生物的合成方法
CN101265216B (zh) * 2007-12-18 2012-06-27 重庆华邦胜凯制药有限公司 4-(取代乙氰基)-苯腙衍生物及其合成方法
MX2013001872A (es) * 2010-08-16 2013-09-02 Boehringer Ingelheim Int Inhibidores de oxadiazol de la produccion de leucotrieno.
WO2018011375A1 (en) * 2016-07-13 2018-01-18 Universite Paris Descartes Meclozine derivatives and diclazuril derivatives for use in the prevention and/or the treatment of disorders associated to the inflammation induced by p. acnes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2149645A1 (de) * 1970-10-07 1972-09-14 Pfizer 2-Phenyl-as-triazin-3.5-(2H,4H)-dione und die Verwendung dieser Verbindungen zur Bekaempfung der Coccidiose
US3912723A (en) * 1971-03-29 1975-10-14 Pfizer 2-Phenyl-as-triazine-3,5(2H,4H)diones
US3883528A (en) * 1974-04-19 1975-05-13 Pfizer Preparation of 2(aryl)-as-triazine-3,5(2H,4H)-dione coccidiostats
CA1244024A (en) * 1984-08-01 1988-11-01 Gustaaf M. Boeckx .alpha.- ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN- 2(3H)-YL)BENZENEACETONITRILES
GB8602342D0 (en) * 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones
EP0476439A1 (de) * 1990-09-18 1992-03-25 Bayer Ag Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
RU2146674C1 (ru) * 1993-10-15 2000-03-20 Такеда Кемикал Индастриз, Лтд. Производные триазина, способы их получения, антипротозойная композиция, добавка в пищу животных, способ ингибирования протозои у животных

Also Published As

Publication number Publication date
EP1000040B1 (en) 2007-06-13
AU8973898A (en) 1999-02-08
DE69837922D1 (de) 2007-07-26
WO1999002505A1 (en) 1999-01-21
KR20010014049A (ko) 2001-02-26
CA2294145A1 (en) 1999-01-21
HUP0004687A3 (en) 2002-03-28
EE200000016A (et) 2000-10-16
NZ502180A (en) 2000-11-24
HUP0004687A2 (hu) 2002-02-28
IL133916A0 (en) 2001-04-30
CN1262679A (zh) 2000-08-09
NO20000063D0 (no) 2000-01-06
TR200000153T2 (tr) 2000-07-21
ID24390A (id) 2000-07-13
EP1000040A1 (en) 2000-05-17
NO20000063L (no) 2000-03-10
AU742145B2 (en) 2001-12-20
HRP20000003A2 (en) 2000-12-31
BR9811678A (pt) 2000-09-19
PL337947A1 (en) 2000-09-11
SK183999A3 (en) 2000-08-14
ATE364597T1 (de) 2007-07-15
TW496865B (en) 2002-08-01
JP2002511882A (ja) 2002-04-16
AR013360A1 (es) 2000-12-27

Similar Documents

Publication Publication Date Title
ZA9811599B (en) Ortho-anthranilamide derivatives as anti-coagulants.
ZA99254B (en) Benzosulfone derivatives.
ZA988078B (en) Substituted oxindole derivatives.
ZA982853B (en) Nicotinamide derivatives.
PL332040A1 (en) Substitution 6,5-heterobicyclic derivatives
PL331988A1 (en) Substitution 6,6-heterobicyclic derivatives
ZA97521B (en) 19-Nor-pregnene derivatives.
ZA992191B (en) Piperidine derivatives.
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
ZA986089B (en) Novel IL-5 inhibiting 6-azauracil derivatives.
ZA987055B (en) Substituted 4-benzoylpyrazoles.
ZA987058B (en) Substituted 4-benzoylpyrazoles.
ZA991550B (en) Cyclohexanediole derivatives.
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
ZA200101830B (en) Piperidine derivatives.
ZA982436B (en) Thiazolimine derivatives.
IL136500A0 (en) 1,4-diazacycloheptane derivatives
ZA986095B (en) 6-azauracil derivatives as IL-5 inhibitors.
ZA987B (en) Substituted 4-benzoylpyrazoles.
ZA988206B (en) Piperidinylmethyloxazolidinone derivative.
ZA979781B (en) Piperidine derivatives.
CY2322B1 (en) Benzoaeguequinoline derivatives.
ZA971167B (en) Heterocyclyl-ergoline derivatives.
GB9701427D0 (en) Gemcitabine derivatives
IL143766A0 (en) Il-5 inhibiting 6-azauracil derivatives